Real-world data in the United Kingdom: opportunities and challenges

被引:27
作者
McDonald, Laura [1 ]
Lambrelli, Dimitra [1 ]
Wasiak, Radek [1 ]
Ramagopalan, Sreeram V. [1 ]
机构
[1] Evidera, Metro Bldg,6th Floor,1 Butterwick, London W6 8DL, England
来源
BMC MEDICINE | 2016年 / 14卷
关键词
Real-world evidence; Care.data; United Kingdom; MEDICAL-RESEARCH; OPT-OUT; REGISTRY; CONSENT; TRIAL;
D O I
10.1186/s12916-016-0647-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Real-world data is that collected outside the constraints of controlled clinical trials and is increasingly informing decision-making in healthcare. The landscape of real-world data in the United Kingdom is set to evolve over the coming months as the government plans to build on databases currently in place by collecting patient data from all family practices and linking this information with hospital records. This initiative, called care. data, has the potential to be an invaluable resource. However, the programme has been criticized on grounds of data privacy, which has led to an extended delay in its implementation and the expectation that a large number of people will opt out. Opt-outs may introduce substantial biases to the dataset, and understanding how to account for these presents a significant challenge for researchers. For the scope and quality of real-world evidence in the United Kingdom to be realised, and for this information to be used effectively, it is essential to address this challenge.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Real-world data in the United Kingdom: opportunities and challenges
    Laura McDonald
    Dimitra Lambrelli
    Radek Wasiak
    Sreeram V. Ramagopalan
    BMC Medicine, 14
  • [2] Real-world evidence for coverage decisions: opportunities and challenges
    Hampson, Grace
    Towse, Adrian
    Dreitlein, William B.
    Henshall, Chris
    Pearson, Steven D.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (12) : 1133 - 1143
  • [3] Real-World Data and Real-World Evidence in Healthcare in the United States and Europe Union
    Zou, Kelly H.
    Berger, Marc L.
    BIOENGINEERING-BASEL, 2024, 11 (08):
  • [4] Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer
    Lueftner, Diana
    Hartkopf, Andreas D.
    Lux, Michael P.
    Overkamp, Friedrich
    Tesch, Hans
    Titzmann, Adriana
    Poschke, Patrik
    Wallwiener, Markus
    Muller, Volkmar
    Beckmann, Matthias W.
    Belleville, Erik
    Janni, Wolfgang
    Fehm, Tanja N.
    Kolberg, Hans-Christian
    Ettl, Johannes
    Wallwiener, Diethelm
    Schneeweiss, Andreas
    Brucker, Sara Y.
    Fasching, Peter A.
    BREAST CARE, 2021, 16 (02) : 108 - 114
  • [5] The challenges and opportunities in using real-world data to drive advances in healthcare in East Asia: expert panel recommendations
    Crane, Gracy
    Lim, John C. W.
    Gau, Churn-Shiouh
    Xie, Jipan
    Chu, Laura
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (09) : 1543 - 1551
  • [6] Data Science Methods for Real-World Evidence Generation in Real-World Data
    Liu, Fang
    ANNUAL REVIEW OF BIOMEDICAL DATA SCIENCE, 2024, 7 : 201 - 224
  • [7] Controversies Surrounding Renal Denervation: Lessons Learned From Real-World Experience in Two United Kingdom Centers
    Burchell, Amy E.
    Chan, Kenneth
    Ratcliffe, Laura E. K.
    Hart, Emma C.
    Saxena, Manish
    Collier, David J.
    Jain, Ajay K.
    Mathur, Anthony
    Knight, Charles J.
    Caulfield, Mark J.
    Paton, Julian F. R.
    Nightingale, Angus K.
    Lobo, Melvin D.
    Baumbach, Andreas
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (06) : 585 - 592
  • [8] Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process
    Zisis, Konstantinos
    Pavi, Elpida
    Geitona, Mary
    Athanasakis, Kostas
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2024, 27
  • [9] Editorial: Real-world data and real-world evidence in lung cancer
    Gristina, Valerio
    Eze, Chukwuka
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [10] When can real-world data generate real-world evidence?
    Rahman, Motiur
    Dal Pan, Gerald
    Stein, Peter
    Levenson, Mark
    Kraus, Stefanie
    Chakravarty, Aloka
    Rivera, Donna R.
    Forshee, Richard
    Concato, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)